A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis

Details for Australian Patent Application No. 2002221339 (hide)

International Classifications

Event Publications

13 February 2003 Application Open to Public Inspection

Published as AU-B-2002221339

27 April 2006 Application Accepted

Published as AU-B-2002221339

24 August 2006 Standard Patent Sealed

23 December 2010 Alteration of Name

The name of the patentee has been altered to The Sydney Children's Hospitals Network (Randwick and Westmead) (incorporating The Royal Alexandra Hospital for Children) 2003

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.